{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01354405","recordId":"NCT01354405","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01354405-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01354405.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01354405.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2011-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-05-13","publishedAt":"2026-08-23","recordId":"NCT01354405","recordSha256":"4c7a93e5820bf4afc2ef26f13dd9dbf31b12f41e42aa3662b81b6eeabcaf1779","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01354405?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2013-04-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2013-04-02","publishedAt":"2026-08-23","recordId":"NCT01354405","recordSha256":"6ce510c874bc56ff5ddf1a2b02529f2b7a46af2baaf2cb20865a446171b5a779","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01354405?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2014-07-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2014-07-08","publishedAt":"2026-08-23","recordId":"NCT01354405","recordSha256":"b9b0f1cc3a1562402b502b711c604bb73be270383f6f7bc13b8adb70f803114d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01354405?a=3&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"0d0b05ba362b40b1b01980a43ab2e82ab5316daa1983408d485461d8131e5029"}}